Effects of cholesterol-bearing pullulan (CHP)-nanogels in combination with prostaglandin E1 on wound healing

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 91, Issue 1, 2009, Pages 55-60

  Kobayashi, Hiroshi ^a   Katakura, Osamu ^a   Morimoto, Nobuyuki ^a   Akiyoshi, Kazunari ^a   Kasugai, Shohei ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cholesterol bearing pullulan; Drug delivery system; Nanogel; Prostaglandin E1; Wound healing

Indexed keywords

CONTROL GROUPS; DRUG DELIVERY SYSTEM; HYDROPHOBIC DRUG; NANOGEL; NANOGELS; NEOVASCULARIZATION; PROSTAGLANDIN E1; PULLULANS; SIZE REDUCTIONS; SKIN DEFECTS; WISTAR RAT; WOUND CLOSURE; WOUND HEALING;

BEARINGS (STRUCTURAL); CHOLESTEROL; DRUG DELIVERY; SKIN; TISSUE ENGINEERING;

NANOSTRUCTURED MATERIALS;

CHOLESTEROL BEARING PULLULAN; NANOGEL; NANOMATERIAL; POLYURETHAN; PROSTAGLANDIN E1; PULLULAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BANDAGE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EPITHELIZATION; HISTOLOGY; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OINTMENT; RAT; SKIN DEFECT; SKIN ULCER; WISTAR RAT; WOUND CLOSURE; WOUND DRESSING; WOUND HEALING;

ALPROSTADIL; ANIMALS; BIOCOMPATIBLE MATERIALS; CHOLESTEROL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GELS; GLUCANS; MALE; MATERIALS TESTING; MOLECULAR STRUCTURE; RATS; RATS, WISTAR; WOUND HEALING;

EID: 70049105658     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31373     Document Type: Article

References (28)

1. Winter G. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature 1962;193:293-294.
2. Vogt P, Andree C, Breuing K, Liu P, Slama J, Helo G, Eriksson E. Dry, moist, and wet skin wound repair. Ann Plast Surg 1995;34:493-499; discussion 499-500.
3. Purna S, Babu M. Collagen based dressings - A review. Burns 2000;26:54-62.
4. Akiyoshi K, Deguchi S, Tajima H, Nishikawa T, Sunamoto J. Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide. Macromolecules 1993;26:3062-3068.
5. Akiyoshi K, Deguchi S, Tajima H, Nishikawa T, Sunamoto J. Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide. Macromolecules 1997;30:857-861. (Pubitemid 127567689)
6. Akiyoshi K, Taniguchi I, Fukui H, Sunamoto J. Hydrogel nanoparticle formed by self-assembly of hydrophobized polysaccharide. Stabilization of adriamysin by complexation. Eur J Pharm Biopharm 1996;42:286-290. (Pubitemid 26294959)
7. Akiyoshi K, Kobayashi S, Shichibe S, Mix D, Baudys M, Kim S, Sunamoto J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: Complexation and stabilization of insulin. J Control Release 1998;54:313-320. (Pubitemid 28412662)
8. Ikuta Y, Katayama N, Wang L, Okugawa T, Takahashi Y, Schmitt M, Gu X, Watanabe M, Akiyoshi K, Nakamura H, Kuribayashi K, Sunamoto J, Shiku H. Presentation of a major histocompatibility complex class 1-binding peptide by monocyte- derived dendritic cells incorporating hydrophobized polysaccharide- truncated HER2 protein complex: Implications for a polyvalent immuno-cell therapy. Blood 2002;99:3717-3724. (Pubitemid 34534543)
9. Kato N, Hasegawa U, Morimoto N, Saita Y, Nakashima K, Ezura Y, Kurosawa H, Akiyoshi K, Noda M. Nanogel-based delivery system enhances PGE2 effects on bone formation. J Cell Biochem 2007;101:1063-1070. (Pubitemid 47253709)
10. Kuroda K, Fujimoto K, Sunamoto J, Akiyoshi K. Hierarchical self-assembly of hydrophobically modified pullulan in water: Gelation by networks of nanoparticles. Langmuir 2002;18:3780-3786. (Pubitemid 35383640)
11. Zhang J, Maruyama K, Iwatsuki K, Ono I, Kaneko F. Effects of prostaglandin E1 on human keratinocytes and dermal fibroblasts: a possible mechanism for the healing of skin ulcers. Exp Dermatol 1994;3:164-170. (Pubitemid 24309231)
12. Shirakawa J, Horikawa Y, Yaku H, Takeshi M, Obara H. Combined therapy with prostaglandin E1 ointment and lumbar sympathetic ganglion block on intractable skin ulcers accompanied by Bürger's disease. Masui 1992;41:1000-1003.
13. Morisaki S. Effect of topical application of prostaglandin E1 ointment on chronic skin ulcers and relation between tissue oxygen tension and its clinical efficacy. Skin Res 1993;35:210-218. (Pubitemid 23140477)
14. Wittaya-areekul S, Prahsarn C. Development and in vitro evaluation of chitosan-polysaccharides composite wound dressings. Int J Pharm 2006;313:123-128.
15. Hinrichs W, Lommen E, Wildevuur C, Feijen J. Fabrication and characterization of an asymmetric polyurethane membrane for use as a wound dressing. J Appl Biomater 1992;3:287-303.
16. Wright K, Nadire K, Busto P, Tubo R, McPherson J, Wentworth B. Alternative delivery of keratinocytes using a polyurethane membrane and the implications for its use in the treatment of full-thickness burn injury. Burns 1998;24:7-17. (Pubitemid 28195778)
17. Taylor J, Laity P, Hicks J, Wong S, Norris K, Khunkamchoo P, Johnson A, Cameron R. Extent of iron pick-up in deforoxamine- coupled polyurethane materials for therapy of chronic wounds. Biomaterials 2005;26:6024-6033. (Pubitemid 40805608)
18. Suzuki Y, Tanihara M, Nishimura Y, Suzuki K, Kakimaru Y, Shimizu Y. A novel wound dressing with an antibiotic delivery system stimulated by microbial infection. ASAIO J 1997;43:M854-M857. (Pubitemid 27473225)
19. Dressler D, Barbee W, Sprenger R. The effect of Hydron burn wound dressing on burned rat and rabbit ear wound healing. J Trauma 1980;20:1024-1028. (Pubitemid 11209661)
20. Kim H, Choi E, Oh J, Lee H, Park S, Cho C. Possibility of wound dressing using poly(L-leucine)/poly(ethylene glycol)/poly(L-leucine) triblock copolymer. Biomaterials 2000;21:131-141.
21. Yannas I, Burke J. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 1980;14:65-81.
22. Yannas I, Burke J, Orgill D, Skrabut E. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. Science 1982;215:174-176. (Pubitemid 12178103)
23. Boyce S, Christianson D, Hansbrough J. Structure of a collagen- GAG dermal skin substitute optimized for cultured human epidermal keratinocytes. J Biomed Mater Res 1988;22:939-957. (Pubitemid 18221459)
24. Muzzarelli R, Guerrieri M, Goteri G, Muzzarelli C, Armeni T, Ghiselli R, Cornelissen M. The biocompatibility of dibutyryl chitin in the context of wound dressings. Biomaterials 2005;26:5844-5854. (Pubitemid 40798275)
25. Choi Y, Hong S, Lee Y, Song K, Park M, Nam Y. Study on gelatin-containing artificial skin. I. Preparation and characteristics of novel gelatin-alginate sponge. Biomaterials 1999;20:409-417.
26. Choi Y, Lee S, Hong S, Lee Y, Song K, Park M. Studies on gelatin-based sponges. Part III: A comparative study of cross-linked gelatin/alginate, gelatin/hyaluronate and chitosan/hyaluronate sponges and their application as a wound dressing in full-thickness skin defect of rat. J Mater Sci Mater Med 2001;12:67-73. (Pubitemid 32108411)
27. Hashimoto T, Suzuki Y, Tanihara M, Kakimaru Y, Suzuki K. Development of alginate wound dressings linked with hybrid peptides derived from laminin and elastin. Biomaterials 2004;25:1407-1414. (Pubitemid 37476214)
28. Milio G, Minà C, Cospite V, Almasio P, Novo S. Efficacy of the treatment with prostaglandin E-1 in venous ulcers of the lower limbs. J Vasc Surg 2005;42:304-308. (Pubitemid 41139238)